2016 American Transplant Congress
Barriers to Living Donor Kidney Transplant in the Pediatric Population.
Objective:A shift from living donor transplants to deceased donor transplants has been noted nationwide and is more prominent at some centers than others. Our objective…2016 American Transplant Congress
Risk Prediction of End-Stage Renal Disease in Living Kidney Donors.
Recent studies have shown inreased risk of end stage renal disease (ESRD) in living kidney donors compared to healthy nondonors. Donors must understand the risk…2016 American Transplant Congress
The Prevailing Preference for Left Nephrectomy in Living Donor Transplantation Does Not Adversely Affect Long Term Donor Outcome.
Background: There is a world-wide prevailing clinical bias for removing the left kidney for living donor renal transplant. Both the retrieval and implantation of the…2016 American Transplant Congress
Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
Background;Renal transplantation is the treatment of choice for individuals with end stage renal disease (ESRD).Method; This is a retrospective review of eight live related renal…2016 American Transplant Congress
Quality Assessment and Process Improvement of Thymoglobulin Dosing.
University of Minnesota, Minneapolis.
Thymoglobulin (Thymo) induction is given to prevent early rejection while initiating maintenance immunosuppression. Modification of dosing is common for multiple reasons. Our center recently underwent…2016 American Transplant Congress
Retroperitoneal versus Intraperitoneal Hand Assisted Laparoscopic Donor Nephrectomy: A Case Matched Study.
Abdominal Transplant Unit, Guy's Hospital, London, United Kingdom.
Although hand assisted laparoscopic donor nephrectomy (HALDN) has become a standard of care for living kidney procurement in most centres it is not clear if…2016 American Transplant Congress
Real Time Assessment of Kidney Transplant Indication Biopsies by Microarrays: First Results of the INTERCOMEX Study.
1University of Alberta, Edmonton, Canada; 2ATAGC, Edmonton, Canada.
Oncology uses central molecular tissue assessment (MTA) to guide management but the potential of this approach in transplantation is not known. We undertook a prospective…2016 American Transplant Congress
Are Prior Living Kidney Donors with ESRD Being Listed and Receiving Transplantation Priority in a Timely Manner?
BackgroundPrior living donors (PLDs) receive very high priority on the kidney (KI) waiting list (WL). Programs must submit requests for PLD priority to the UNOS…2016 American Transplant Congress
Age-Based High GFR Associates with Clinical Risk Among Potential Living Donors, but Only with Increased Nephron Number Among Approved Donors.
1Mayo Clinic, Arizona; 2Mayo Clinic, Rochester; 3Cleveland Clinic, OH.
Background:Association of high GFR with clinical and kidney structural characteristics among living donors has not been studied.Methods: Study cohort:potential kidney donors evaluated at Mayo Clinic…2016 American Transplant Congress
Negative Impact of Anticardiolipid Antibodies on 1-Year Renal Allograft Estimated Glomerular Filtration Rate: A Cohort Study.
In kidney transplant recipients, antiphospholipid positive tests without antiphospholipid syndrome (APS) were described up to 38% of patients and seem to be associated with thrombotic…
- « Previous Page
- 1
- …
- 87
- 88
- 89
- 90
- 91
- …
- 101
- Next Page »